Advertisement

Index by author

February 01, 1994; Volume 45,Issue 2

  1. Hiratsuka, A

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  2. Hughes, L

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  3. Itoh, S

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  4. Iversen, L J

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

  5. Jackman, A

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  6. Janowsky, A

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;

  7. Jensen, C J

    1. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
      C J Jensen, N P Gerard, T W Schwartz and U Gether
      Molecular Pharmacology February 1994, 45 (2) 294-299;

  8. Johnson, M P

    1. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
      M P Johnson, R J Loncharich, M Baez and D L Nelson
      Molecular Pharmacology February 1994, 45 (2) 277-286;

  9. Kamataki, T

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  10. Kanematsu, T

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 15) Next »
Back to top

In this issue

Advertisement